1. Most Discussed
  2. Gainers & Losers
NEU $1.24

Could be a rare week!

  1. hottod

    3,236 Posts.
    Perhaps it’s just pure chance, but 28 February, which comes exactly 60 days after December 30, happens to be Rare (Orphan) Disease Day around the globe. The day caps off Rare Disease Week, which has been raising awareness of rare diseases since 2009.

    Rare Disease Week will even be marked on Capitol Hill. The likely attendant publicity would make the end of February a perfect time for Neuren to announce a new orphan drug designation.

    The chances of Neuren receiving orphan therapy designation for NNZ-2566 in the treatment of Rett Syndrome are excellent, in my opinion. It is not the first company to have sought orphan drug designation for a therapy for Rett Syndrome. Three other drugs have already received the designation, but none as yet has received marketing approval.




Before making any financial decisions based on what you read, always consult an advisor or expert.

The HotCopper website is operated by Report Card Pty Ltd. Any information posted on the website has been prepared without taking into account your objectives, financial situation or needs and as such, you should before acting on the information or advice, consider the appropriateness of the information or advice in relation to your objectives, financial situation or needs. Please be aware that any information posted on this site should not be considered to be financial product advice.

From time to time comments aimed at manipulating other investors may appear on these forums. Posters may post overly optimistic or pessimistic comments on particular stocks, in an attempt to influence other investors. It is not possible for management to moderate all posts so some misleading and inaccurate posts may still appear on these forums. If you do have serious concerns with a post or posts you should report a Terms of Use Violation (TOU) on the link above. Unless specifically stated persons posting on this site are NOT investment advisors and do NOT hold the necessary licence, or have any formal training, to give investment advice.


Thank you for visiting HotCopper

We have detected that you are running ad blocking software.

HotCopper relies on revenue generated from advertisers. Kindly disable your ad blocking software to return to the HotCopper website.

I understand, I have disabled my ad blocker. Let me in!

Need help? Click here for support.